ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance

ANI Pharma (ANIP) Misses Q4 EPS by 8c, Offers FY Guidance

February 23, 2016 8:03 AM EST

ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.52, $0.08 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $18.04 million versus the consensus estimate of $18.13 million.

GUIDANCE:

ANI Pharma sees FY2016 revenue of $105-120 million, versus the... More